DGCI approves Zydus Cadila’s ‘Virafine’

HealthDGCI approves Zydus Cadila’s ‘Virafine’

Date:

DGCI approves Zydus Cadila’s ‘Virafine’

New Delhi: The Drugs Controller General of India has approved the use of another injection for the treatment of corona infections. On Friday, DGCI approved the use of Zydus Cadilla’s Pegylated Interferon Alpha-2b, Virafine, in the treatment of adult corona infections.

This injection made by Zydus Cadila was previously used for liver disease Hepatitis B. Its full name is Pegylated Interferon Alpha-2b. After growing cases of corona, it is now decided to use it against the corona virus. For this, testing has been done at 25 centers across the country.

Share post:

Subscribe

Popular

More like this
Related

What Is a Recession? Explained Simply

Whenever economies slow down, news reports often mention the...

Delhi High Court Backs Temporary Telegram Ban Ahead of NEET-UG Re-Exam

The Delhi High Court on Friday upheld the Centre's...

Tamil Nadu Assembly Follows Tradition, Begins With Tamil Anthem and Ends With National Anthem

The Tamil Nadu Assembly on Thursday followed its long-standing...